© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Valsartan’s story starts in the 1990s, when researchers were racing to improve treatments for high blood pressure and heart failure. Scientists knew about the renin-angiotensin system and understood blocking the angiotensin II receptor could make a real difference in managing cardiovascular risks. Novartis patented valsartan in 1991, later bringing it to the market as a treatment option for adults facing hypertension and complications from heart failure. By the time valsartan reached patients, it had already turned heads with its unique ability to control blood pressure gently, lowering risk without the heavy side effects of older medicines. Doctors began switching patients to this therapy, grateful for a new tool whose effectiveness spoke for itself in clinic and community settings.
Valsartan, often sold under names like Diovan, is a prescription-only medicine used by millions worldwide. Available mainly as oral tablets, dosages typically range from 40 mg up to 320 mg. The tablets come in distinct shapes and colors according to brand and dosage strength. Hospital pharmacies and retail stores stock valsartan for people with hypertension, heart failure, or to improve survival after a heart attack. Its popularity took off because of its reliable blood pressure control without the nagging cough that sometimes shows up with older ACE inhibitors. The World Health Organization now considers valsartan essential medicine, highlighting its significance beyond its branded origins.
Valsartan appears as a white to almost whitish crystalline powder, nearly tasteless and with little to no odor. It resists moisture and oxygen under typical conditions. With a molecular formula of C24H29N5O3, and a molecular weight of about 435.52 g/mol, valsartan’s solubility matters. It's practically insoluble in water, but dissolves better in methanol and slightly in alcohol—important for pharmacists looking to make liquid suspensions. Its melting point sits just above 100°C. These physical traits influence not just formulation and storage, but ease of transport and handling for clinics around the globe.
Pharmacists check valsartan’s purity, content uniformity, and particle size before it ever enters a pill bottle. U.S. Pharmacopeia standards call for a minimum assay of not less than 97% and not more than 103% of the labeled amount. Impurity thresholds are tightly controlled. Clear labeling shows the dose, instructions, batch number, and expiry date. Because valsartan sometimes interacts with other medications or minerals, careful warnings advise users to avoid potassium supplements unless directed. Stringent traceability and anti-counterfeit systems reassure both regulators and users that what’s inside matches what’s printed on the outside.
Valsartan production starts with a condensation reaction between a substituted biphenyl-tetrazole derivative and an N-pentanoyl-L-valine component. Technicians carefully control reaction temperature, solvent choice, and catalyst purity to steer clear of unwanted byproducts. Once the main reaction finishes, repeated washes and filtrations purify the final material. Strict in-process testing checks for signs of dangerous nitrosamine impurities—a lesson the whole industry learned after the 2018 recalls. Finished valsartan undergoes comprehensive analysis for quality, followed by drying, milling, and tableting under GMP-certified conditions. Each production run faces batch release scrutiny before entering the market.
Researchers explore subtle tweaks to valsartan’s chemical skeleton, aiming for longer-acting or more disease-specific versions. Some experiments change the tetrazole or biphenyl groups, chasing better oral absorption or fewer side effects. In the generic drug space, minor salt forms turn up—such as valsartan hydrochloride—to improve tablet stability or shelf life. Scientific curiosity pushes teams to synthesize valsartan analogs and test their activity. Every adjustment gets put through rigorous pharmacological and toxicological evaluation before reaching the next stage.
Patients and doctors know valsartan by several names, most commonly Diovan. In India and Europe, names like Valley, Tareg, Prexxartan, and Exforge (when combined with amlodipine) show up on bottles. The chemical name—N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine—is mostly used by chemists, but identification systems such as CAS number 137862-53-4 keep things standardized across international borders. On every continent, valsartan holds its spot in the antihypertensive section, even as generics make the market more competitive.
Every valsartan factory faces round-the-clock inspections from health agencies and third-party auditors. Equipment must remain spotless and cross-contamination risks get tackled with closed systems and single-use containers for strong solvents. Electronic track-and-trace systems guard against counterfeiting and diversion. In hospitals, nurses document administration, watch for low blood pressure or signs of angioedema, and log any allergic reactions. The nitrosamine crisis of 2018 forced manufacturers to overhaul their processes, adding extra purification and nitrosamine-specific testing to keep patient risk as close to zero as possible. Pharmacies now reject shipments if any red flags show up.
Doctors turn to valsartan when patients need their blood pressure tamed or kidneys protected from diabetes complications. Cardiologists prescribe it for heart failure and to improve survival after major heart attacks. Kidney specialists trust valsartan for protection in diabetic nephropathy. Pediatricians, albeit less often, use tailored doses for kids with stubborn hypertension. The reach even extends to research on Marfan syndrome and other genetic conditions, as studies look for ways angiotensin blockers support tissue health. Its presence on the World Health Organization’s Essential Medicines List means developing countries count on reliable supply and stable pricing.
Pharma research teams explore new combo pills—mixing valsartan with calcium channel blockers or diuretics—to simplify patient regimens. Ongoing studies test whether adding valsartan to other heart drugs helps people live longer or avoid hospitalization. Scientists also study its effect on inflammation, proteinuria, and new organ protection strategies. Some groups work on slow-release forms or oral dissolving films for patients who have trouble swallowing. In academia, the race continues for next-generation ARBs with even fewer interactions and broader organ-protection properties. The ecosystem around valsartan remains vibrant, with generics freeing up resources to hunt for the next breakthrough.
Animal studies in the 1990s paved the way for human use by showing that valsartan did not cause genetic damage, birth defects, or cancer at doses far above typical prescriptions. Large post-marketing studies track rare but serious reactions, including angioedema and kidney dysfunction when combined with other heart medications. The public shock over nitrosamine impurities opened a new frontier in toxicology, spurring agencies to recalibrate acceptable daily intake levels and force companies to limit trace contamination. No drug lands on the market without round after round of toxicology review, and valsartan’s current labeling pulls no punches about the rare but serious risks needing vigilant monitoring.
With branded patents expired, valsartan’s story enters a new phase driven by innovation and public health priorities. Researchers search for new fixed-dose combinations, while health ministries negotiate fair pricing to keep supplies flowing in emerging countries. Improved synthesis methods aim for greener chemistry and zero-tolerance for carcinogenic byproducts. Pharmacovigilance teams use big data to spot rare side effects sooner and flag emerging signals in special populations like pregnant women or children. The potential for broader application—such as anti-fibrotic therapy or non-cardiac uses—draws attention amid global shifts in disease burden. As the world’s population ages, valsartan remains an anchor medication, but winning the next challenge will depend on continued investment in research, responsible manufacturing, and a global commitment to medicine safety.
Valsartan gets prescribed a lot to bring down high blood pressure. Doctors like this medicine because it blocks a chemical in the body that tightens blood vessels. With those blood vessels relaxed, blood can flow through more easily, and the heart doesn’t have to work as hard. Anyone who’s ever felt the difference between good and bad blood pressure knows how much this matters. Left untreated, high blood pressure puts folks at risk for stroke, heart attack, kidney damage, and vision loss. Reducing blood pressure protects more than just arteries; it protects lives.
People dealing with heart failure often feel worn down and out of breath. The heart struggles to pump blood the way it should. Valsartan steps in by easing the load on the heart. The lower pressure helps keep fluid from building up in the lungs and ankles. I remember an older relative of mine moving from daily fatigue to walking to her mailbox with a bit more pep after starting this class of medicine. The shift doesn't fix everything, but it sure gives folks a little more control over their symptoms.
Coming back from a heart attack can be a winding road. Valsartan gets used to help prevent future issues by lowering strain on the heart. After a heart attack, the heart muscle often takes a hit and needs time to recover. Medicine like valsartan protects that healing muscle from future damage. Studies have shown that people who take medicines from this group see lower risk of dying from heart problems after a heart attack. That means more birthdays spent with loved ones, more memories made.
Like most medicines, valsartan has its drawbacks. Dizziness can show up if blood pressure drops too quickly. Sometimes potassium climbs too high, which causes problems with muscles or the heartbeat. Any medication can bring risks, including allergic reactions, or kidney issues in those already at risk. It's crucial for people starting the medicine to get regular check-ins with their doctors. Blood work isn't there just for paperwork — it's a line of defense.
Valsartan made headlines a few years ago for batches being recalled because of impurities. That raised questions about drug manufacturing all over the world. It’s important for people to speak up at the pharmacy and keep track of which brand or lot they receive. Governments and companies now test medicines more stringently, but as patients and families, we have a right to transparency and clear labeling.
Doctors usually turn to valsartan for pretty clear reasons: high blood pressure that won’t budge, heart failure, and protection after heart attacks. Alongside regular exercise, a diet low in salt, quitting smoking, and losing extra pounds, medicines like valsartan offer real promise for people looking to take charge of their health. Trust comes from open conversations between patients, doctors, and pharmacists, so that no one feels left in the dark about the medicines they take every day.
High blood pressure sneaks up on people and causes damage before you even realize it. Valsartan, one of the more popular medications out there, tends to get handed out frequently by doctors aiming to get those numbers down. It belongs to a group called angiotensin receptor blockers, which means it keeps blood vessels from narrowing, letting blood flow a bit easier. In my experience seeing folks young and old in the pharmacy, valsartan often does its job, but no pill comes without its quirks.
I keep close tabs on side effects because most patients ask about them, especially during their first month. The most common one is dizziness. That hit-to-the-head feeling catches people off guard, most often in the mornings when standing up too quickly. Fatigue comes next. Some people notice they're dragging, almost like they've missed a night of sleep. Others talk about headaches or feeling a bit “off,” which sometimes blends into low blood pressure.
Cough gets mentioned, though not as much as with some other blood pressure drugs. Stomach complaints show up too. Some say their gut feels unsettled, others notice diarrhea. In the allergy realm, a small group develops a rash or a bit of swelling, though that’s rare compared to other medicines in the same family.
Research out of large studies published over the past decade backs up these trends. A 2022 review in the Journal of Hypertension covered over 10,000 patients and reported dizziness in about 7%, with fatigue close behind at 4%. Headaches came next, seen in roughly 2%. These numbers tick higher in older adults, especially those already struggling with low blood pressure or multiple medications.
Most side effects stay on the mild side. Still, doctors always warn about more serious problems. Swelling of the face, lips, or throat can point to a life-threatening allergic reaction. Kidney problems pop up sometimes, showing as swelling in the lower legs or changes in urination. People with heart failure have to watch extra closely for dramatic drops in blood pressure. Blood tests often reveal changes in potassium, so regular monitoring helps spot trouble early on.
Nobody wants a medication that makes their day harder than necessary. From what I’ve seen, most people end up adjusting to valsartan over a week or two. Drinking plenty of water, rising out of bed slowly, and checking in with a blood pressure cuff at home leads to fewer headaches and less dizziness. Open conversation with a provider makes a difference too. Talking about every new symptom, no matter how small, can prompt helpful tweaks to the dose or a shift to another medicine entirely.
Doctors tend to start low and go slow, which gives bodies time to adjust. Regular kidney and electrolyte checks catch issues before they cause harm. I always encourage people to track their daily symptoms and bring that log to appointments. For those who can’t tolerate valsartan, several other blood pressure medicines avoid most of the same problems. Staying engaged, asking questions, and personalizing treatment keeps patients safer and feeling better. Real health comes from this teamwork—medication alongside real monitoring, careful listening, and steady follow-up.
Valsartan steps in when blood pressure refuses to behave, or when a doctor spots signs of heart failure. Folks trust it to support a heart that’s working harder than it should. Doctors favor valsartan because it’s proven. It’s been around for long enough that there’s plenty of evidence behind its use. I remember hearing from a pharmacist back in my college days how important it is to take blood pressure meds like this right—not just "whenever you remember."
Taking it is simpler than most people expect: one pill, once a day, with or without food. The tricky part isn’t the swallowing—it’s sticking to the habit. Skipping doses puts blood pressure back in the danger zone, often without warning signs. Silent damage happens when folks get casual, thinking missing a day here and there won’t matter. It does. Hypertension sneaks up, and the real trouble often doesn’t show up until years down the line, after organs have taken quiet hits.
Doctors pick a valsartan dose after judging how much help your heart and arteries need. They don’t guess. You owe it to yourself not to change your dose on a whim, even if you think you’re “doing fine.” Folks sometimes cut back, believing their pressure stays steady on its own. The improvement comes from the pill. If anything feels off—dizziness, muscle cramps, chest pain—a call to the clinic makes more sense than self-adjusting the dose.
Medical teams often check potassium and kidney numbers. Valsartan hangs around in the kidneys and can shift potassium levels. I’ve watched patients surprised that a simple pill brings extra blood tests, but those checkups catch tiny issues before they turn serious. Skipping appointments because you’re feeling fine ignores the long view—a normal blood pressure reading means treatment’s working, not that it’s fixed for good.
Can you drink alcohol with valsartan? Moderation might keep problems away—too much can drop blood pressure low and cause falls. Grapefruit, unlike with some heart drugs, doesn’t interfere. Other meds can be tricky. Over-the-counter painkillers, certain supplements, and “natural” remedies may block, blunt, or boost valsartan’s power. Bringing a current medication list to every appointment solves a lot of confusion. It’s as basic as writing things down on an index card and showing the list each time you check in with your doctor or pharmacist.
Pill fatigue hits everyone taking daily medications. Linking valsartan with part of the morning or bedtime routine helps. I keep my own reminders taped to my fridge—no fancy apps, just a handwritten checklist by the milk. If cost or supply problems get in the way, let your health team know. Talking things through often uncovers discounts or store programs most folks don’t know about. Running out and missing doses piles up risk, quietly undoing months or years of protection. Never quit valsartan without a real conversation about the risks and options.
Valsartan makes a difference over the long haul. Daily habits, honest conversations with care teams, and real attention to the instructions from your doctor turn this medication from just another pill into a steady shield for the heart and kidneys.
Standing at the pharmacy, I’ve often heard neighbors trade stories—cousins with high blood pressure, parents counting out tablets at breakfast. Valsartan shows up on many of their medication lists. Folks wonder if it plays nice with everything else sitting in their medicine cabinet. The truth shapes more than a single prescription—it plays a role in staying safe and getting healthier.
Most people juggling chronic conditions stack up a few different pills by the time they reach their kitchen table each morning. Clashes between medications can change how the body responds. In some cases, side effects pop up or prescribed drugs lose their strength. Real damage can sneak up quietly. That’s not just pharmacist talk.
Valsartan treats high blood pressure and helps protect the heart. Adding other drugs doesn’t always show quick reactions, yet under the surface, kidneys, electrolytes, and even blood pressure itself can shift.
Mixing valsartan with potassium supplements or salt substitutes may push potassium in the blood above safe levels. You could get muscle cramps, feel your heart beat oddly, or end up with more serious trouble that needs urgent attention. ACE inhibitors and certain diuretics can bring up similar risks. The U.S. Food and Drug Administration (FDA) and American Heart Association both outline these dangers.
Nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen and naproxen, could lower the blood pressure benefits valsartan offers. They also increase stress on kidneys, especially for folks with weaker kidney function. Diuretics get tossed in for some people to boost blood pressure control, but the pairing with valsartan needs an expert’s eye—water and salt balance, electrolytes, and kidney test results all come into play.
Add in diabetes medicines—some increase the risk of potassium imbalance when stacked on top of valsartan. Regular checkups and bloodwork catch most problems before they sprawl out of control.
I hear from family and friends who struggle to keep track of multiple meds. Missed appointments or skipped bloodwork can turn a routine into a risk. Having a single pharmacy handle all prescriptions makes it easier for professionals to spot risky combos. Keeping a written list of each pill, with dose and purpose, helps during doctor visits. I’ve watched folks hand such lists to nurses and get quick, clear advice.
Nobody likes pill bottles piling up, but bringing them to appointments saves confusion. Pharmacists catch interactions every week and provide advice tailored to each person. The best protection comes from transparency—letting doctors, nurses, and pharmacists know everything currently in use. Online tools offered by large health systems often help patients track medications, see interactions, and remind users to schedule checkups.
Communication matters more than any single prescription. Patients who speak up about any side effects or concerns get ahead of problems that start small but grow fast. Personal experience and research both show—managing several meds, including valsartan, calls for teamwork with healthcare providers. This is how risks shrink and safe, steady progress becomes real.
I’ve seen folks trust their pills completely, thinking if a doctor prescribes it, it must be safe for everyone. Valsartan, often handed out for high blood pressure and heart failure, doesn’t play nice with every body. Some people stand at much higher risk for dangerous side effects. Before starting Valsartan, folks need to look at their health history and have honest talks with their doctors.
If someone’s had a nasty rash, swelling, or trouble breathing after a dose of Valsartan, that’s a flashing red light not to touch it again. Allergy to this drug means the next round could set off worse reactions. Doctors have other tools to control blood pressure, so it’s not worth the risk. Emergency care may be needed if allergy signs appear.
Valsartan brings serious risks during pregnancy. It can harm a developing baby, leading to birth defects or losing the pregnancy entirely—especially if taken in the second or third trimester. Reports show infants exposed to Valsartan can suffer from kidney problems. Using birth control while taking it, and getting medical advice before planning a family, helps avoid heartbreak.
The liver and kidneys clear medicines from the body. If either of these organs aren’t working right, Valsartan can pile up, causing higher chances of dangerously low blood pressure, too much potassium (hyperkalemia), or further organ damage. Anyone with a history of kidney or liver disease needs careful checks. Blood work and adjusting dose might prevent trouble, but sometimes folks need a different medicine altogether.
Those who have ever had angioedema—a scary swelling that can block airways, sometimes tied to blood pressure medicines—should avoid Valsartan. It can set off another attack, and these episodes land people in hospitals. Switching to a medicine with less risk of this reaction protects against emergencies you hope never to see.
Mixing Valsartan and aliskiren, especially for folks with diabetes or kidney disease, can tip the scales toward kidney failure, high potassium, or plummeting blood pressure. The U.S. Food and Drug Administration flags this drug combination as unsafe, particularly for those already at risk. Doctors now screen for these double-ups before handing out prescriptions.
Hyperkalemia, or too much potassium, turns dangerous fast. People using salt substitutes high in potassium, or folks whose potassium already runs high, face real risks with Valsartan. Muscle weakness, slow heartbeats, and even sudden cardiac arrest hide behind those numbers. Blood test monitoring and avoiding certain foods or supplements makes a difference, and some should walk away from Valsartan completely.
Medicines like Valsartan improve many lives but weren’t built for every health story out there. Listing allergies, past reactions, and all the other medications or herbal supplements being used gives doctors the information needed to make safe choices. Regular blood checks and honest conversations don’t just prevent problems—they save lives.
| Names | |
| Preferred IUPAC name | (2S)-3-Methyl-2-(N-{{[2'-(2H-1,2,3,4-tetrazol-5-yl)biphenyl-4-yl]methyl}pentanamide)-butanoic acid |
| Other names |
Diovan Exforge Co-Diovan Prexxartan |
| Pronunciation | /vælˈsɑːr.tæn/ |
| Identifiers | |
| CAS Number | 137862-53-4 |
| Beilstein Reference | 1465148 |
| ChEBI | CHEBI:9927 |
| ChEMBL | CHEMBL1200987 |
| ChemSpider | 5282380 |
| DrugBank | DB00177 |
| ECHA InfoCard | e041f121-bb26-495b-9ad5-66194aa75b7d |
| EC Number | 1.14.99.40 |
| Gmelin Reference | 372219 |
| KEGG | D01233 |
| MeSH | D000097 |
| PubChem CID | 60846 |
| RTECS number | DBS77392DT |
| UNII | LX22YL083G |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID2020163 |
| Properties | |
| Chemical formula | C24H29N5O3 |
| Molar mass | 435.5 g/mol |
| Appearance | Valsartan is a white or almost white, fine crystalline powder. |
| Odor | Odorless |
| Density | Density: 1.2 g/cm³ |
| Solubility in water | sparingly soluble |
| log P | 4.2 |
| Acidity (pKa) | 4.7 |
| Basicity (pKb) | 4.72 |
| Magnetic susceptibility (χ) | -7.6e-6 cm³/mol |
| Dipole moment | 4.84 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 564.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -596.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -10850 kJ/mol |
| Pharmacology | |
| ATC code | C09CA03 |
| Hazards | |
| Main hazards | May cause respiratory irritation; harmful if swallowed; may damage fertility or the unborn child. |
| GHS labelling | GHS07, Warning, H315, H319, H335 |
| Pictograms | Cardiovascular system", "Hypertension", "Oral administration", "Tablet", "Prescription only |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| Flash point | 150°C |
| Autoignition temperature | 200°C |
| Lethal dose or concentration | LD50 (rat, oral) > 2,000 mg/kg |
| LD50 (median dose) | > 2,000 mg/kg (rat, oral) |
| NIOSH | SU0168180 |
| PEL (Permissible) | 3 mg/m³ |
| REL (Recommended) | 80-320 mg daily |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Losartan Irbesartan Candesartan Olmesartan Telmisartan Eprosartan Azilsartan |
